CardioWise
CardioWise, Inc.: Pioneering cardiac imaging analysis software for comprehensive heart health insights.
Founded
2012CardioWise, Inc.: Pioneering cardiac imaging analysis software for comprehensive heart health insights.
CardioWise, Inc., founded with a mission to revolutionize cardiac health diagnostics, focuses on developing advanced healthcare software. Their core product is a non-invasive Cardiac Computed Tomography (cCT) analysis software that integrates with cardiac magnetic resonance imaging to provide detailed quantitative analysis of the myocardium, arteries, and valves. The software generates a 3D model of the human heart, aiding in accurate diagnosis and better patient outcomes. CardioWise primarily serves the U.S. market, aiming to enhance clinical workflows through innovative AI algorithms.
Notable figures associated with CardioWise include leading medical professionals and tech innovators who have contributed to the development and implementation of their technology. The company has garnered attention for launching SQuEEZ®, an AI-driven diagnostic tool, at the Society of Cardiovascular Computed Tomography (SCCT). CardioWise's impact is evident in its ability to improve diagnostic accuracy and patient care, positioning itself as a significant player in the cardiac imaging analysis sector.
Companies similar to CardioWise include Cardiac Insight, Myocardial Solutions, InvisionHeart and Heartflow.
CardioWise was founded in 2012.
CardioWise's headquarters is located in Fayetteville, AR, US.
CardioWise's most recent funding round was for $300k (USD) in March 2022.
As of Mar 11, 2022, CardioWise has disclosed funding of $820k (USD). Undisclosed round amounts are excluded.
CardioWise has 8 employees as of Feb 5, 2024.
